{"id":58113,"date":"2026-06-04T21:52:57","date_gmt":"2026-06-04T12:52:57","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4599\/"},"modified":"2026-08-23T12:58:47","modified_gmt":"2026-08-23T03:58:47","slug":"company-4599","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4599\/","title":{"rendered":"STEMRIM INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4599","DATE":"2026-01-09","longName":"StemRIM","company_name_ja":"","fullTimeEmployees":45,"address":"","phone":"","website":"https:\/\/stemrim.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":279,"financialCurrency":"","marketCap":17488,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-31.16,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":700,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:13:16.839148\", \"ticker\": \"4599\", \"ticker_full\": \"4599.T\", \"company_name\": \"STEMRIM INC\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"1\", \"strong_buy\": 1, \"buy\": 0, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 298.0, \"high\": 700.0, \"low\": 700.0, \"mean\": 700.0, \"median\": 700.0}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 50.37, \"institution_pct\": 0.17, \"major_holders\": [{\"label\": \"\", \"value\": 50.37}, {\"label\": \"\", \"value\": 0.17}, {\"label\": \"\", \"value\": 0.33}, {\"label\": \"\", \"value\": 5.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"StemRIM, a biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally. The company offers TRIM2, a peptide drug, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, myocardial infarction\/cardiomyopathy, liver cirrhosis, and knee osteoarthritis. It also provides pre-clinical stage products, including TRIM3 and TRIM4 for the treatment of various tissue damage diseases; and TRIM5, a molecule for tissue repair, as well as SR-GT1, a stem cell gene therapy. The company was incorporated in 2006 and is headquartered in Ibaraki, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:19:45.333198\", \"ticker\": \"4599\", \"ticker_full\": \"4599.T\", \"company_name\": \"STEMRIM INC\", \"company_info\": {\"name_en\": \"STEMRIM INC\", \"long_name\": \"StemRIM\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/stemrim.com\", \"employees\": 45, \"country\": \"Japan\", \"city\": \"Ibaraki\", \"address\": \"Saito Bio-Incubator\", \"description\": \"StemRIM, a biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally. The company offers TRIM2, a peptide drug, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, myocardial infarction\/cardiomyopathy, liver cirrhosis, and knee osteoarthritis. It also provides pre-clinical stage products, including TRIM3 and TRIM4 for the treatment of various tissue damage diseases; and TRIM5, a molecule for tissue repair, as well as SR-GT1, a stem cell gene therapy. The company was incorporated in 2006 and is headquartered in Ibaraki, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 350.2, \"deviation\": 1.94, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 315.08, \"deviation\": 13.3, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 304.48, \"deviation\": 17.25, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 293.32, \"deviation\": 21.71, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": -31.16, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2076083000.0, \"operating_income_fmt\": \"-\u00a521\u5104\", \"ebit\": -2018824000.0, \"ebit_fmt\": \"-\u00a520\u5104\", \"net_income\": -2022166000.0, \"net_income_fmt\": \"-\u00a520\u5104\", \"eps\": -32.98, \"operating_margin\": 0, \"total_assets\": 9080415000.0, \"total_assets_fmt\": \"\u00a591\u5104\", \"total_equity\": 8894534000.0, \"total_equity_fmt\": \"\u00a589\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 8410449000.0, \"total_cash_fmt\": \"\u00a584\u5104\", \"equity_ratio\": 97.95, \"de_ratio\": 0.0, \"current_ratio\": 131.47, \"operating_cf\": -1881497000.0, \"operating_cf_fmt\": \"-\u00a519\u5104\", \"investing_cf\": -4784000.0, \"investing_cf_fmt\": \"-\u00a54.8M\", \"financing_cf\": 78966000.0, \"financing_cf_fmt\": \"\u00a579.0M\", \"free_cf\": -1886339000.0, \"free_cf_fmt\": \"-\u00a519\u5104\", \"net_margin\": 0, \"roe\": -22.73, \"roa\": -22.27}, {\"year\": 2023, \"revenue\": 2350000000.0, \"revenue_fmt\": \"\u00a524\u5104\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 142392000.0, \"operating_income_fmt\": \"\u00a51\u5104\", \"ebit\": 170265000.0, \"ebit_fmt\": \"\u00a52\u5104\", \"net_income\": 168350000.0, \"net_income_fmt\": \"\u00a52\u5104\", \"eps\": 2.69, \"operating_margin\": 6.06, \"total_assets\": 10706482000.0, \"total_assets_fmt\": \"\u00a5107\u5104\", \"total_equity\": 10370458000.0, \"total_equity_fmt\": \"\u00a5104\u5104\", \"total_debt\": 531000.0, \"total_debt_fmt\": \"\u00a5531,000\", \"total_cash\": 10217764000.0, \"total_cash_fmt\": \"\u00a5102\u5104\", \"equity_ratio\": 96.86, \"de_ratio\": 0.0, \"current_ratio\": 47.99, \"operating_cf\": 1135315000.0, \"operating_cf_fmt\": \"\u00a511\u5104\", \"investing_cf\": -344000.0, \"investing_cf_fmt\": \"-\u00a5344,000\", \"financing_cf\": 202602000.0, \"financing_cf_fmt\": \"\u00a52\u5104\", \"free_cf\": 1134965000.0, \"free_cf_fmt\": \"\u00a511\u5104\", \"net_margin\": 7.16, \"roe\": 1.62, \"roa\": 1.57}, {\"year\": 2022, \"revenue\": 22976000.0, \"revenue_fmt\": \"\u00a523.0M\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -1980687000.0, \"operating_income_fmt\": \"-\u00a520\u5104\", \"ebit\": -1946084000.0, \"ebit_fmt\": \"-\u00a519\u5104\", \"net_income\": -1948307000.0, \"net_income_fmt\": \"-\u00a519\u5104\", \"eps\": -32.92, \"operating_margin\": -8620.68, \"total_assets\": 9597373000.0, \"total_assets_fmt\": \"\u00a596\u5104\", \"total_equity\": 9404943000.0, \"total_equity_fmt\": \"\u00a594\u5104\", \"total_debt\": 3672000.0, \"total_debt_fmt\": \"\u00a53.7M\", \"total_cash\": 8880191000.0, \"total_cash_fmt\": \"\u00a589\u5104\", \"equity_ratio\": 97.99, \"de_ratio\": 0.0, \"current_ratio\": 128.96, \"operating_cf\": -1404565000.0, \"operating_cf_fmt\": \"-\u00a514\u5104\", \"investing_cf\": -330000.0, \"investing_cf_fmt\": \"-\u00a5330,000\", \"financing_cf\": 112859000.0, \"financing_cf_fmt\": \"\u00a51\u5104\", \"free_cf\": -1404897000.0, \"free_cf_fmt\": \"-\u00a514\u5104\", \"net_margin\": -8479.75, \"roe\": -20.72, \"roa\": -20.3}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-58113","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>STEMRIM INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4599\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4599\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4599\/\",\"name\":\"STEMRIM INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T12:52:57+00:00\",\"dateModified\":\"2026-08-23T03:58:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4599\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4599\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4599\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STEMRIM INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STEMRIM INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4599\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4599\/","url":"https:\/\/japanir.jp\/en\/company\/company-4599\/","name":"STEMRIM INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T12:52:57+00:00","dateModified":"2026-08-23T03:58:47+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4599\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4599\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4599\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"STEMRIM INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/58113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=58113"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=58113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}